Search
for
Sort by
Research 151–180 of 1000+
- JAK Inhibitors for Treatment of Alopecia Areata
- JAK inhibitors and alopecia areata
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- Emerging drugs for alopecia areata: JAK inhibitors
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Under Development JAK Inhibitors for Dermatologic Diseases
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- The role of janus kinases in the treatment of autoimmune skin diseases
- Therapeutic expansion of JAK inhibitors in Chinese dermatological practice: beyond atopic dermatitis to novel autoimmune frontiers
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- The Role of JAK Inhibitors in Atopic Dermatitis, Alopecia Areata, and Vitiligo: A Review article
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Treatment of alopecia areata with JAK inhibitors
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Jak inhibitors in the treatment of alopecia areata - a literature review
- Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Use of intramuscular triamcinolone acetonide in intermediate responders to janus kinase inhibition for alopecia areata: Case report
- Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata